Financial Services Capital Markets & Investment Management Growth Equity

Late-Stage Growth Rounds

High-stakes financial decisions requiring trust, structured diligence, and coordinated stakeholders.

Insight Partners General Atlantic Warburg Pincus Tiger Global
Inside this journey
  1. Founder & Board Discovery

    Align on capital needs, primary vs. secondary objectives, dilution targets, valuation expectations, timeline, and decision-makers (founder, board, advisors).

    Discovery Questions

    Start Here: Your One‑Sentence Story

    • In one sentence, how do you describe the company and the core opportunity we should understand right away?
    • Which revenue band best describes your last 12 months of ARR / revenue? Options: $50M–$100M, $100M–$200M, $200M–$350M, $350M–$500M, >$500M
    • What round are you raising now, and roughly how much capital are you targeting? Options: Series D, Series E, Growth/Expansion (post‑Series E), Other
    • How would you summarize, in plain terms, the three primary uses of proceeds you expect for this raise?
    • Who is owning the process on your side—founder, CEO, CFO, banker, or another advisor? (select all that apply) Options: Founder/CEO, CFO/Finance Lead, Board Chair/Board Member, Investment Bank/Placement Agent, Legal Counsel, Other

    What’s Actually At Stake?

    • If this round doesn’t land when planned, what will be the single biggest negative consequence for the business?
    • Which of these describes the primary objective for this raise? Options: Accelerate go‑to‑market and growth (primary capital), Fund M&A or inorganic growth, Provide secondary liquidity to employees/early investors, Extend runway while optimizing margins, Other
    • How important is limiting dilution versus maximizing valuation—choose the priority that reflects your board/founder preference? Options: Minimize dilution first, Maximize valuation first, Balance both equally, Depends on investor terms
    • Quantitatively, what dilution range would feel acceptable to you for this round? (give a percent or range)
    • How would you describe the board’s appetite for giving up governance (board seats, veto rights) in exchange for a higher valuation or strategic partner? Options: Comfortable with one or more new board seats, Prefer observers only, Very conservative—limited governance changes, Open depending on investor

    Who Holds the Keys — Board, Advisors, and Hidden Vetoes

    • When the board has to say yes, what’s the most common reason a deal gets slowed or blocked?
    • What is your current board composition and voting threshold for approving a financing? Options: Founder + independent majority, Founder holds special voting rights, Investor majority, Board requires supermajority, Other
    • Which outside advisors materially influence decisions on financing terms (select all that apply)? Options: Investment bank, PE/growth investor advisor, Legal counsel, Big‑4/accounting advisor, Family office/advisor, Other
    • Tell us about a past board conversation on capital that changed the course of the company—what happened and why did it matter?
    • Who, beyond the board, must sign off on the final documents (e.g., major shareholders, founders, lenders)?

    Money, Mechanics, and Control — Hard Terms, Soft Consequences

    • What governance or control provisions would be an absolute deal breaker for you?
    • Do you have a firm preference for the investor taking a board seat, an observer role, or no formal governance role? Options: Board seat required, Observer preferred, No governance role desired, Flexible depending on investor
    • What types of covenants (financial covenants, information rights, restricted actions) are you prepared to accept, and which feel excessive?
    • For the split between primary and secondary proceeds, what allocation feels right to you? Options: Primarily primary capital (>80% primary), Balanced (50/50), Primarily secondary (>80% secondary), No secondary planned
    • How important is it that co‑investors be aligned on follow‑on reserve and exit strategy? Options: Critical, Important, Nice to have, Not important

    Valuation, Dilution, and the Emotional Ledger

    • What valuation range would signal to you that an investor truly understands and respects the company’s trajectory?
    • How tied are your valuation expectations to the prior round price and protections granted to earlier investors? Options: Very tied, Somewhat tied, Not tied—market sets price, Unclear
    • How do you expect to handle employee equity communications if there’s meaningful dilution or a secondary component? Options: Proactive townhalls and written comms, Advisory sessions for key hires only, Minimal communication, Other
    • Are there anti‑dilution or ratchet protections you cannot accept? Tell us which and why.
    • What would a realistic post‑money cap table look like (ownership % ranges for founders, employees, new investor)?

    Timeline & Speed: Tradeoffs Between Momentum and Terms

    • If you had to choose: would you rather close faster at slightly worse economics, or take more time to negotiate materially better terms? Options: Close fast, Take time for better terms, Depends on market and investor
    • What is your target close date and what internal milestones must be met before then? Options: <30 days, 30–60 days, 60–90 days, 90+ days
    • How ready is your diligence package—cap table, audited financials, customer metrics, legal docs? Options: Fully ready, Mostly ready with some gaps, Not ready—work to do, We’ll need help preparing
    • What timeline risks keep you up at night (e.g., board availability, regulatory approvals, audit timing)?
    • Would you consider an exclusivity window if it meaningfully shortens the path to a signed term sheet? Options: Yes, comfortable, Maybe—depends on length, No

    Secondary Liquidity — Who Gets Cash and Why?

    • How important is it to provide liquidity to early employees or founders in this round? Options: Very important, Somewhat important, Not important, Prefer to keep primary only
    • If offering secondary, which groups should be prioritized (select all that apply)? Options: Early employees, Founders, Seed/early investors, Key hires, Other
    • Do you anticipate tax, consent, or ROFR/ROFO constraints that could complicate secondaries? Options: Yes, several, A few minor issues, No major constraints, Unsure
    • How would you like us to balance secondary requests with the message to remaining team members about upside?
    • What visibility do you need into an investor’s approach to secondary liquidity before inviting them into the process? Options: Full plan and examples, High‑level intent, Minimal—discuss later

    Beyond the Wire: What Real Value Looks Like to You

    • Investors promise operational help—what three specific outcomes would make you call that support transformational?
    • Which portfolio operations modules would move the needle fastest for you? (pick top 2) Options: CFO + finance transformation, Go‑to‑market scaling, International expansion, Strategic M&A support, Talent & leadership hiring, Data science/analytics
    • Do you want a hands‑on operating partner embedded post‑close, or a remote advisory capability? Options: Embedded operating partner, Remote advisory, Combination, Undecided
    • Share an example where an investor’s ops team helped you (or a peer) in a way that mattered—what changed?
    • Would you expect references from portfolio founders at a similar stage before advancing to term discussions? Options: Yes—required, Helpful but not required, Not necessary

    Risk Signals & Deal Killers — Let’s Surface Them Early

    • Be candid: what known risks or unresolved issues should every investor see upfront?
    • Which of these is a material risk for your business today? Options: Customer concentration, Revenue recognition complexity, Regulatory/licensing risk, Key person dependency, Supply chain/partner dependency, Litigation
    • Have there been recent audits, restatements, or accounting red flags we should know about? Options: Yes—significant, Yes—minor, No, Prefer to discuss privately
    • If we surfaced a risk that could delay close, how would you prefer we handle communication to the board and employees? Options: Full transparency immediately, Selectively with board first, Handle privately until resolved, Other
    • What mitigation steps are already in motion for your top two risks?

    Decision Comfort & Next Steps — What Will Make This Easy?

    • What would give you high confidence in an investor within the first two meetings? Options: Clear alignment on valuation/dilution, Strong sector track record, Operational plan for value creation, Fast diligence cadence, Reference calls with portfolio founders
    • Who on your team should be involved in the next conversation and what role will each person play?
    • What materials can you share within 72 hours to accelerate diligence (select all that apply)? Options: Audited financials, Cap table, Data room link, Customer metrics/KPIs, Legal documents, Other
    • How would you rate your current appetite for exclusivity if it significantly shortens timeline to term sheet? Options: High—comfortable, Conditional—short window only, Low—prefer open process, Undecided
    • Finally, what’s the single next step you want from us to make progress in the coming week?
  2. Investor Fit Experience

    Translate the firm’s sector expertise, portfolio founder outcomes, and operations playbook into the customer’s context using realistic scenarios and references.

    Experience Meetings

    • Pre-Session: Current State & Consequence Alignment
    • Investor Fit Scenario Experience (Diagnosis → Proof → Validation)
    • Portfolio Founder Reference Review
    • Operations Playbook Mapping Workshop
    • Fit Decision & Next Steps (Proceed to Deal Structure?)
    • Introductions & Objectives
    • Elicit explicit validation (or rejection) of each scenario and capture required adjustments or constraints.
    • Identify the top 3 operational modules and metrics that matter to the customer for the next-stage planning.
    • Surface any non-negotiable deal or governance requirements that would block progression.
    • Firm: deliver scenario playbooks (detailed interventions, expected KPIs, timelines, and comparable portfolio case metrics) within 3 business days.
    • Customer: provide feedback on each scenario's realism and list constraints or priorities to be incorporated.
    • Schedule founder reference calls for cases used in the scenarios to validate outcomes and timelines.
    • Reference Session Briefing
    • Obtain third-party validation of the firm’s claimed outcomes and timelines in comparable companies.
    • Surface practical details about operating cadence, board interactions, and personnel changes required for success.
    • Identify any warning signs or mismatches that would require reassessment before proceeding.
    • Firm: compile a reference dossier with verbatim founder quotes, KPI deltas, and timelines tied to each scenario.
    • Customer: confirm whether the referenced outcomes change their confidence and list any remaining doubts.
    • Update the scenario playbooks based on insights from founder references.
    • Reconfirm Future-State & Success Metrics
    • Agree a concrete 90–120 day operations plan with measurable milestones and named owners.
    • Tie every ops action back to the customer's current problem and the agreed future-state outcomes.
    • Surface resource requirements, estimated timelines, and any dependencies that could delay execution.
    • Firm: produce the draft 100-day plan with milestones, owners, and estimated resource commitments within 3 business days.
    • Customer: confirm internal owners and capacity to execute the 100-day plan or propose alternatives.
    • Both: schedule a follow-up to resolve any resource or timeline gaps prior to Deal Structure discussions.
    • Recap: Agreed Current State, Consequence, Future State, and 100-Day Plan
    • Arrive at a clear mutual decision (proceed / pause / decline) to move to the Deal Structure stage.
    • If proceeding, agree non-binding commercial guardrails and a timeline for a term sheet and exclusivity request.
    • Assign owners and deadlines for the term-sheet draft, diligence kickoff, and ops 100-day activation.
    • Document any final gaps that must be closed prior to structure and set explicit owners to resolve them.
    • Firm: prepare a non-binding term-sheet outline and a proposed exclusivity window proposal if both sides agree to proceed.
    • Customer: confirm internal approvals and availability for diligence kickoff dates and provide any remaining artifacts.
    • Both: finalize the schedule for the Deal Structure & Ops Scope kickoff meeting and circulate invites with owners.
    • Produce and agree on a single-sentence current-state that the entire room accepts.
    • Quantify the immediate financial and strategic consequences of not addressing the problem.
    • Define one clear future-state sentence that will be used to focus the Solution Experience.
    • Align on decision-makers, timeline, and deliverables required for the Investor Fit Experience session.
    • Founder: deliver requested datasets and one-page current-state by [date].
    • Firm: prepare and circulate a one-page portfolio-case index and 2–3 relevant case summaries mapped to the customer's sector.
    • Schedule the Scenario-Based Investor Fit Experience and reserve 90–120 minutes with core attendees.
    • Opening Recap (Current State, Consequence, Future State)
    • Show concrete, portfolio-backed pathways that prove the firm can deliver the agreed future-state in the customer's specific context.
    • Review of Pre-work & Key Metrics
    • Founder Reference 1 — GTM Expansion Case
    • Hypothesis of Fit
    • Open Issues & Deal-Readiness Checklist
    • Module Mapping — GTM & Revenue Ops
    • Craft the One-Sentence Current State
    • Scenario A — GTM & Revenue Acceleration (Diagnosis → Proof)
    • Module Mapping — Finance & IPO Readiness
    • Mutual Fit Assessment
    • Founder Reference 2 — IPO Readiness / CFO Advisory
    • Quantify Consequences
    • Synthesis: Cross-Case Outcomes & Credibility Signals
    • Module Mapping — International Expansion & Legal/Compliance
    • Validation Check A
    • Commercial Guardrails & Proposed Timeline
    • Module Mapping — Talent & Org
    • Q&A and Red-Flag Resolution
    • Define the One-Sentence Future State
    • Agree Next Steps, Owners & Deadlines
    • Scenario B — International Expansion & Margin Optimization (Diagnosis → Proof)
    • Decision Map & Timeline
    • Milestones, Owners & Timeline (90–120 Day Plan)
  3. Deal Structure & Ops Scope

    Define investment size, primary vs. secondary split, governance (board/observer), covenants, use of proceeds, and portfolio operations modules with measurable milestones.

    Scope Configuration

    • Deploy Primary Growth Capital Tranche
    • Execute Secondary Liquidity for Selling Shareholders
    • Seat Investor Director on Company Board
    • Place Interim CFO for Public‑Readiness
    • Recruit and Onboard C‑Suite and VP Hires
    • Implement Public‑Company Financial Reporting Systems
    • Execute Sales Compensation and Territory Realignment
    • Launch International Market Entry and Local Entity Setup
    • Execute Margin Improvement and Cost‑Savings Program
    • Manage Strategic M&A Transaction Execution
    • Embed Portfolio Operations Pod with Management Team
    • Draft and Deliver IPO Investor Presentation
    • Execute Sponsor‑to‑Sponsor Secondary Sale

    Scope Questions

    Deploy Primary Growth Capital Tranche

    • Is a primary capital tranche required as part of this financing? Options: Yes, No, Undecided
    • If yes, what is the target primary tranche size (USD or range)? Options: Less than $50M, $50M–$200M, $200M–$500M, Over $500M, Enter exact amount
    • What are the prioritized uses of primary proceeds (e.g., international expansion, product R&D, M&A)?
    • Are there tranche conditions or milestone-linked drawdowns (timing, KPIs, board sign-off)? Options: No – single close, Yes – performance milestones, Yes – board/consent-based, Other
    • Who will own tranche execution and deliverables on the company side (role/title) and what documentation is required (funding schedule, wire instructions)?

    Execute Secondary Liquidity for Selling Shareholders

    • Is secondary liquidity requested in this round and for which shareholder groups (employees, founders, early investors)? Options: No secondary, Employees only, Founders only, Early investors/angels, Mixed
    • What is the approximate secondary amount or percentage of equity expected to be sold (USD or %)? Options: Less than $10M, $10M–$50M, $50M–$200M, >$200M, Enter exact amount or %
    • Are there preferred mechanics for secondary (co-investor facilitated, escrow, pro-rata allocations)? Options: Direct buyback by investor, Co-investor facilitated, Escrowed until close, Sponsor coordinates allocations, Other
    • Do selling shareholders require tax, legal, or liquidity advisory support to execute their secondary sales? Options: Yes – tax advisory, Yes – legal advisory, Yes – liquidity structuring, No
    • Are there any transfer restrictions, right-of-first-refusal, or approval processes that could affect secondary execution? Options: None known, Board approval required, Existing investors’ ROFR applies, Employee plan limitations, Other

    Seat Investor Director on Company Board

    • Is the expectation to take a full board seat, observer seat, or conditional observer-to-seat conversion? Options: Full board seat, Observer only, Observer to board seat on milestone, Undecided
    • When should the investor director/observer take their seat (immediately at close, after governance changes, after a milestone)? Options: Immediate at close, After charter/bylaw amendment, After milestone/KPI, Other
    • What are the expected governance rights and limits (voting rights, reserved matters, information rights) the investor requires?
    • Who on the company side will coordinate director onboarding and materials (CRO/CFO/Company Secretary)?
    • Are there any existing board composition constraints, investor consents, or staggered terms that affect seating? Options: No constraints, Staggered board terms, Consent required from existing investors, Company charter limits, Other

    Place Interim CFO for Public‑Readiness

    • Is an interim CFO required, and if so, what is the anticipated engagement length (months)? Options: No interim CFO needed, 3 months, 3–6 months, 6–12 months, 12+ months
    • What are the top three priorities for the interim CFO (e.g., financial reporting, audit readiness, SEC filings, FP&A uplift)?
    • What reporting structure and authorities will the interim CFO have (direct to CEO, full signatory rights, hire/fire authority)?
    • Are there specific industry or public-company experience requirements for the interim CFO (sector, IPOs, cross-border reporting)? Options: Public company IPO experience, Cross-border reporting (IFRS/US GAAP), Scale-up CFO experience, Industry-specific experience, No specific requirement
    • What immediate deliverables are expected from the interim CFO (audit-ready financials, SEC filing templates, FP&A models)?

    Recruit and Onboard C‑Suite and VP Hires

    • Which roles are in-scope for recruitment (check all that apply)? Options: CEO, CFO, COO, CPO/CTO, Chief Revenue Officer, VP Sales, VP Marketing, Other
    • What is the target timeline to fill these roles (immediate, 30–60 days, 3 months, 6+ months)? Options: Immediate (30 days), 30–60 days, 60–90 days, 3–6 months, 6+ months
    • Are these permanent hires, interim placements, or retained search mandates? Options: Permanent hire, Interim/contract, Retained executive search, Hybrid
    • What are the critical success criteria for each role (experience, KPIs, cultural fit) and compensation band constraints?
    • Will the firm’s operations team be involved in onboarding and 100-day plans for new executives? Options: Yes – full onboarding support, Yes – limited onboarding, No – company-led

    Implement Public‑Company Financial Reporting Systems

    • What accounting and ERP systems are currently in place (e.g., NetSuite, Oracle, Workday, QuickBooks)? Options: NetSuite, Oracle, Workday, QuickBooks, Custom/Other
    • What gaps exist for public-company reporting (consolidation, segment reporting, stock-based comp, intercompany eliminations)?
    • Is the company reporting under US GAAP, IFRS, or does it need dual reporting capabilities? Options: US GAAP, IFRS, Dual reporting required, Undecided
    • Are external auditors engaged or expected (timing for first audit ready period)? Options: Audit engaged, Audit to be engaged – timeline needed, No audit planned
    • What timelines and deliverables are needed (monthly close schedule, investor reporting pack, 10-Q/10-K templates)?

    Execute Sales Compensation and Territory Realignment

    • What are the primary goals of the sales redesign (improve coverage, align comp to ARR, reduce CAC)?
    • How large is the sales organization (number of reps, managers, regions)? Options: Less than 10, 10–50, 50–200, 200+
    • Do you currently have documented comp plans and quota attainment data to model changes? Options: Yes – documented and available, Partially documented, No – needs design from scratch
    • Are there regulatory or country-specific constraints for comp changes (local labor laws, contractual quotas)? Options: No constraints, Yes – local labor law considerations, Yes – existing employment contracts limit changes, Unknown
    • What timeline and acceptance criteria are required for rollout (pilot, phased, immediate company-wide)? Options: Pilot, Phased rollout, Immediate company-wide, Undecided

    Launch International Market Entry and Local Entity Setup

    • Which countries/regions are targeted for entry in the next 12–24 months?
    • What local capabilities are required at launch (sales, legal entity, payroll, local leadership)? Options: Sales/BD, Local legal entity, Payroll/HR, Local leadership hire, Local finance/GA
    • Do you require assistance with entity type selection, tax registration, and employment compliance? Options: Yes – full entity setup, Yes – tax/registration only, No – using local partners
    • What is the target go-to-market model (direct sales, channel partnerships, distributor, local JV)? Options: Direct sales, Channel/partners, Distributor, Joint venture, Other
    • What timeline and budget constraints apply to market entry and local setup?

    Execute Margin Improvement and Cost‑Savings Program

    • What margin targets are you aiming to achieve and over what timeframe (e.g., +500 bps in 12 months)?
    • Which cost pools are highest priority (COGS, S&M, G&A, R&D, vendor spend)? Options: COGS, Sales & Marketing, G&A, R&D, Vendor/third-party spend
    • Are workforce reductions or reorganizations expected or off the table? Options: Expected and acceptable, Some reorgs but no layoffs, Not acceptable
    • Do you have baseline financial metrics and benchmarking to measure program savings (benchmarks, historical spend)? Options: Yes – benchmarks available, Partial data, No – needs baseline build
    • What governance and reporting cadence should be used to track initiatives and capture savings? Options: Weekly steering committee, Bi-weekly updates, Monthly executive review, Other

    Manage Strategic M&A Transaction Execution

    • Is the M&A scope buy-side, sell-side, bolt-on integration, or divestiture? Options: Buy-side (acquisition), Sell-side (exit process), Bolt-on integration, Divestiture
    • What is the target transaction size and expected timeline to close? Options: Less than $25M, $25M–$100M, $100M–$500M, >$500M, Enter exact amount
    • What level of advisor support is required (financial advisor, legal, tax, IP, integration lead)? Options: Full advisor suite, Financial + legal only, Integration lead only, Other
    • Are there regulatory or foreign investment approvals expected that affect timing or structure? Options: No regulatory approvals expected, Local regulatory clearances needed, CFIUS/foreign investment review, Unknown
    • What post-close integration priorities and owners should be planned (systems, people, go-to-market)?

    Embed Portfolio Operations Pod with Management Team

    • Which portfolio operations modules are required (GTMT, finance transformation, talent, product ops, localization)? Options: Go-to-market, Finance transformation, Talent & recruiting, Product operations, Localization/market entry
    • What is the expected engagement model for the pod (full-time embedded, part-time advisory, project-based)? Options: Full-time embedded, Part-time advisory, Project-based sprints, Hybrid
    • Who will be the primary company sponsor and day-to-day partner for the pod?
    • What measurable milestones and KPIs will define success for the operations pod (revenue lift, margin improvement, hiring milestones)?
    • Do you require the pod to operate on-site, remote, or a mixed cadence, and what is the intended duration? Options: On-site, Remote, Mixed cadence, Duration: enter months

    Draft and Deliver IPO Investor Presentation

    • What is the target timeline for IPO readiness or roadshow (months to target)? Options: 3–6 months, 6–12 months, 12–24 months, Undecided
    • What key financial and operational metrics should be highlighted in the investor presentation?
    • Do you have comps and market positioning materials available, or should benchmarking be performed? Options: Comps available, Benchmarking required, Partial comps available
    • Who will review and approve the draft (CEO, CFO, lead investor, external bankers)? Options: CEO, CFO, Lead investor, Investment bank, Other
    • Are there confidentiality or messaging constraints for pre-IPO communications that we should observe? Options: Yes – strict controls, Moderate controls, No special constraints
  4. Mutual Commit (Term Sheet & Exclusivity)

    Resolve commercial terms, exclusivity window, key conditions precedent, and mutual obligations to move toward signing.

    Agreement Modules

    • Term Sheet (Heads of Terms)
    • Exclusivity / No-Shop Agreement
    • Definitive Subscription / Purchase Agreement
    • Investor Rights & Governance Agreement
    • Conditions Precedent Schedule
    • Escrow & Funds Flow Instructions
    • Secondary Liquidity Allocation Agreement
    • Statement of Work (Portfolio Operations)
    • Side Letter(s) & Founder/Key Employee Terms
    • Confidentiality & Public Announcement Protocol
    • Termination & Break Fee Terms
  5. Deployment

    Operationalize closing and integration with readiness checks, execution, and post-close integration.

    1. Diligence & Closing Readiness

      Confirm data rooms, diligence plan, third‑party audits, regulatory and board approvals, and timeline risks to ensure closability.

      Readiness Questions

      Start Here: One‑Sentence Snapshot

      • In one sentence, what is the primary goal you want this financing to achieve (growth, IPO readiness, secondary liquidity, M&A, etc.)?
      • What is your target raise range (or target investor check) for this round? Options: $100M–$250M, $250M–$500M, $500M–$1B+, Flexible / undecided
      • Which date would you call your ‘target close’ today? Options: Next 30 days, 30–60 days, 60–90 days, 90–180 days, Undetermined
      • Who are the three decision‑makers we should be aligning with (founder(s), CEO, board chair, CFO, lead investor, advisor)?
      • If we slipped one milestone, which stakeholder would feel the most pressure—and why?

      What Could Actually Stop This Deal?

      • If I asked you to name the one issue most likely to derail closing, what would you say?
      • Have you previously experienced a signed term sheet failing to close? If so, what happened? Options: Yes — timing/financing fell apart, Yes — regulatory or approval issue, Yes — diligence uncovered surprises, No — never happened
      • Which of the following risks worries you most right now? Options: Board or shareholder veto, Regulatory approval, Financial restatement or audit issue, Customer concentration, IP or legal dispute, Market/valuation shift
      • How would a failed close affect your business trajectory in the next 12 months—financial runway, hiring, product roadmaps?
      • What contingency plan do you already have if the round stalls? Options: Bridge financing, Cost reduction / runway extension, Smaller strategic round, Pursue M&A, No contingency

      How Ready Is Your Story and Your Data?

      • If an investor asked for audited financials, KPIs, and a unit‑economics model tomorrow, how confident are you you could deliver without extensions? Options: Very confident, Somewhat confident, Would need a short extension, Unprepared
      • Which parts of your data room are fully complete today? Options: Financials (audited/unaudited), Cap table & equity plan, Customer contracts, IP & licensing docs, Compliance / privacy, None are complete
      • What key KPI or metric do you think investors will probe deepest, and why might it create questions?
      • Are there known reconciliation items (ERP vs CRM vs GAAP) that require remediation before diligence? Options: No material recon issues, Minor recon items, Significant recon items pending, Unsure / need review
      • Who on your team will own keeping the data room current during diligence (name and role)?

      Who Holds the Real Veto — and What Would Convince Them?

      • Which single stakeholder (board member, investor, regulator, founder) can block this transaction and what makes them say no?
      • What evidence or assurance would most quickly reduce that stakeholder's reluctance? Options: Board materials and economic modeling, Reference calls with portfolio founders, Stronger governance terms, Escrow or earn‑outs, Regulatory sign‑offs
      • Are there existing investor agreements (ROFRs, consent rights, vetoes) that will require waivers or consents? Options: No, Yes — limited consents, Yes — multiple consents required, Unsure / need legal check
      • Have you run a pre‑brief with your board or lead investor about the proposed economics and governance? What surfaced in that conversation?
      • If we prioritized one action to win over your toughest skeptic this week, what should it be?

      Regulatory, Contractual, and Audit Wildcards

      • Are there active regulatory reviews, enforcement matters, or licensing dependencies that could delay or prevent closing? Options: No known issues, Minor regulatory items, Material regulatory review ongoing, Potential industry approvals needed
      • Do any customer or vendor contracts include change‑of‑control, assignment, or consent clauses that could trigger delays? Options: None, A few requiring consents, Many requiring consents, Unknown — legal review needed
      • Is there litigation or a significant dispute that could materially affect investor willingness to close? Options: No, Yes — disclosed and managed, Yes — unresolved and material, Unsure
      • Which third‑party audit or attestation will investors expect (financial audit, tax, SOC2, penetration test), and which are already in progress? Options: Financial audit (full), Financial review (limited), Tax audit/prep, SOC2 / security audits, Penetration / app security test, None started
      • If an investor requests an independent vendor or technical due diligence, do you have an NDA‑friendly contact who can scope and schedule within 7–10 days? Options: Yes — ready contacts, Yes — need brief prep, No — will take time, Unsure

      Timeline: Where the Real Slips Happen

      • Where do you most expect timeline slippage—legal, financing, approvals, third‑party consents, or internal decision‑making? Options: Legal documentation, Investor funding cycles, Board/regulatory approvals, Third‑party consents, Internal alignment
      • What is your absolute latest acceptable close date before the business plan materially changes? Options: Within 30 days, Within 60 days, Within 90 days, Beyond 90 days
      • Which milestones must be checked off before funds can flow (e.g., audit completion, regulatory sign‑off, escrow setup)? List the top 3.
      • How much buffer have you built into the plan to accommodate unexpected diligence requests? Options: 2 weeks, 1 month, 2–3 months, No buffer
      • Who on your side will be the point person for timetable escalations and daily diligence coordination?

      External Dependencies: Audits, References, and Co‑Investors

      • Which external checks do you expect investors to prioritize (customer reference checks, vendor calls, co‑investor allocation decisions)? Options: Customer references, Vendor/partner calls, Co‑investor commitments, Bank/escrow confirmations, Regulatory references
      • Do you have customer references ready and willing to speak candidly about product, growth and renewal risk? Options: Yes — several ready, Some — need prep, No — not prepared, Prefer limited references
      • Are any co‑investors conditional on certain governance or economic terms being agreed before they commit? Options: No co‑investors, Yes — conditions known, Yes — conditions uncertain, Unsure
      • Which vendor or service provider would cause the biggest delay if they needed to provide a consent or information quickly?
      • What lead time do you realistically need to produce a SOC2, penetration test, or similar security deliverable if requested? Options: Already available, 2–4 weeks, 1–3 months, Longer than 3 months

      Governance, Covenants, and The Hard Conversations

      • If an investor asked for one governance change that you would push back on, what would it be and why?
      • Which governance items are you prepared to accept as‑is, and which are non‑starters (board seats, veto rights, protective provisions)? Options: Board seat(s), Board observer, Protective provisions, Financial covenants, Information rights
      • How do you feel about ongoing reporting cadence post‑close (monthly metrics, quarterly deep dives, board package cadence)? Options: Happy with monthly, Prefer quarterly, Willing but want automation, Concerned about overhead
      • Have you modeled the dilution and governance impact of likely investor terms and shared that with your board? What reaction did you get?
      • What is the one governance concession you could make that would meaningfully speed closing?

      A Brutally Honest Closability Score

      • On a clear scale, how closable is this deal today if no additional issues surface? Options: Highly closable (80–100%), Moderately closable (50–80%), At risk (20–50%), Unlikely (<20%)
      • What's the single biggest action that would move this score up one category within 7 days?
      • Who on your team will own each of these domains during diligence: legal, finance, ops, and external communications? (list names and emails)
      • Which items below are already assigned to a named owner and deadline? Options: Data room completion, Financial audit/tax deliverables, Customer references, Third‑party consents, Governance approvals
      • Would you welcome direct support from our portfolio operations or CFO advisory team to accelerate any of these items? Options: Yes — operations, Yes — CFO advisory, Yes — legal introductions, Not at this time

      Small Wins This Week to De‑risk Closing

      • If you could guarantee one deliverable to investors in the next 7 days, what would you choose? Options: Updated financial model with reconciliations, Complete data room index, Two customer reference calls, Board sign‑off memo, Legal consent list
      • Who will own that deliverable and what is a realistic deadline (date)?
      • What would it take for you to commit to that deadline today (resources, approvals, or external help)?
      • Which of these templates or supports would be most helpful from us right now? Options: Data room index template, Board briefing memo template, Customer reference script, Audit scoping checklist, Legal precedent term sheet
      • Finally, is there any information you want us to hold back from broader investor outreach until specific conditions are met? Options: Yes — hold back sensitive contracts, Yes — hold back personnel details, No — share broadly, Discuss offline
    2. Closing Execution

      Coordinate legal execution, funds flow, escrow, co-investor allocations, and final signings with clear owners and deadlines.

    3. Post-Close Integration & 100-Day Plan

      Launch portfolio operations support, board onboarding, CFO advisory, and the initial 100‑day value capture plan with owners and metrics.

  6. Success & Exit Planning

    Review KPIs, validate outcomes against success signals, capture learnings, and maintain a shared plan for IPO or strategic exit readiness.

    Success Reviews

    • KPI & Success Signal Review
    • Exit Readiness Gap Assessment
    • 100‑Day Value Capture & Operational Milestones
    • Dual‑Track Exit Strategy & Stakeholder Alignment

    Issues & Enhancements

    • Build a simple scorecard/dashboard to surface KPI trends to the board.
    • Opening & Objectives
    • Produce a prioritized list of exit‑readiness gaps with estimated impact and remediation timelines.
    • Assign owners and initial deadlines for each top gap, and agree on required third‑party inputs.
    • Align on the single‑sentence future state of readiness to use for ongoing validation.
    • Draft a remediation roadmap with owners, timeline, and estimated cost for each top gap.
    • Initiate requests for necessary third‑party audits or legal reviews within the agreed timeline.
    • Share targeted portfolio case studies and playbooks relevant to the top 3 gaps.
    • Opening & Plan Objective
    • Agree on the top 6 initiatives and measurable milestones for the next 100 days.
    • Define expected KPI impacts at 30/60/100 day intervals and owners for each initiative.
    • Confirm resource needs and a governance cadence for progress reviews.
    • Publish the 100‑day plan with RACI, milestones, metrics and reporting cadence.
    • Kick off top two initiatives within 7 business days and confirm interim deliverables.
    • Set up the weekly KPI dashboard distribution and executive checkpoint calendar invite.
    • Opening & Desired Decision
    • Get alignment on whether to run dual‑track or commit to a specific exit path.
    • Define explicit decision triggers, timeline, and owners to move from optionality to execution.
    • Agree on a stakeholder communication plan to preserve valuation and optionality.
    • Deliver scenario model workbook with sensitivity analysis and recommended preferred path.
    • Draft board memo outlining triggers, recommended timetable, and communication plan for approval.
    • Schedule standing alignment calls (weekly/biweekly) until the decision trigger is resolved.
    • Confirm a one‑sentence current state that all stakeholders accept.
    • Agree on the 6–8 primary KPIs that define exit readiness and set target thresholds.
    • Quantify immediate valuation or timing consequences for the top KPI gaps.
    • Assign owners and reporting cadence for each primary KPI.
    • Document and circulate agreed KPI definitions, targets, and dashboard wireframe.
    • Assign owners and a weekly reporting cadence for each KPI.
    • Opening & Objectives
    • One‑sentence Current State
    • One‑sentence Current Exit Position
    • One‑sentence Current Initiative State
    • One‑sentence Current Readiness State
    • Prioritized Initiatives & Milestones
    • Domain Gap Identification
    • KPI Deep Dive
    • Scenario Modelling: IPO vs Strategic Sale
    • Proof of Impact Modeling
    • Consequence & Timing Impact
    • Define Decision Triggers & Timing
    • Map KPIs to Success Signals
    • Consequence Modelling
    • Stakeholder Communication & Board Alignment
    • Resourcing, Dependencies & Risk Mitigation
    • Define Future‑State Exit Checklist
    • Validation & Agreement
    • Proof Points & References
    • Validation & Next Steps
    • Validation & Weekly Cadence
    • Agree Prioritization & Next Steps
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.